These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30232796)

  • 1. [Effects of hypotherapy on the motor function of persons with Down's syndrome: a systematic review].
    De Miguel A; De Miguel MD; Lucena-Anton D; Rubio MD
    Rev Neurol; 2018 Oct; 67(7):233-241. PubMed ID: 30232796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentative and alternative communication in children with Down's syndrome: a systematic review.
    Barbosa RTA; de Oliveira ASB; de Lima Antão JYF; Crocetta TB; Guarnieri R; Antunes TPC; Arab C; Massetti T; Bezerra IMP; de Mello Monteiro CB; de Abreu LC
    BMC Pediatr; 2018 May; 18(1):160. PubMed ID: 29751828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underestimating the educability of Down's syndrome children: examination of methodological problems in recent literature.
    Rynders JE; Spiker D; Horrobin JM
    Am J Ment Defic; 1978 Mar; 82(5):440-8. PubMed ID: 147628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial.
    de la Torre R; de Sola S; Hernandez G; Farré M; Pujol J; Rodriguez J; Espadaler JM; Langohr K; Cuenca-Royo A; Principe A; Xicota L; Janel N; Catuara-Solarz S; Sanchez-Benavides G; Bléhaut H; Dueñas-Espín I; Del Hoyo L; Benejam B; Blanco-Hinojo L; Videla S; Fitó M; Delabar JM; Dierssen M;
    Lancet Neurol; 2016 Jul; 15(8):801-810. PubMed ID: 27302362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does screening for Down's syndrome cause anxiety in pregnant women? A systematic review.
    Lou S; Mikkelsen L; Hvidman L; Petersen OB; Nielsen CP
    Acta Obstet Gynecol Scand; 2015 Jan; 94(1):15-27. PubMed ID: 25146713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive executive function in Down's syndrome.
    Rowe J; Lavender A; Turk V
    Br J Clin Psychol; 2006 Mar; 45(Pt 1):5-17. PubMed ID: 16480563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of Alzheimer's disease in Down's syndrome assessed by auditory event-related potentials.
    Blackwood DH; St Clair DM; Muir WJ; Oliver CJ; Dickens P
    J Ment Defic Res; 1988 Dec; 32 ( Pt 6)():439-53. PubMed ID: 2976841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive deficits and associated neurological complications in individuals with Down's syndrome.
    Lott IT; Dierssen M
    Lancet Neurol; 2010 Jun; 9(6):623-33. PubMed ID: 20494326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Hippotherapy to Recover Gross Motor Function in Children with Cerebral Palsy: A Systematic Review and Meta-Analysis.
    Guindos-Sanchez L; Lucena-Anton D; Moral-Munoz JA; Salazar A; Carmona-Barrientos I
    Children (Basel); 2020 Aug; 7(9):. PubMed ID: 32825159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary sialic acid, protein, salivary flow rate, pH, buffering capacity and caries indices in subjects with Down's syndrome.
    Yarat A; Akyüz S; Koç L; Erdem H; Emekli N
    J Dent; 1999 Feb; 27(2):115-8. PubMed ID: 10071468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of objectively measured physical activity levels in individuals with intellectual disabilities with and without Down's syndrome.
    Phillips AC; Holland AJ
    PLoS One; 2011; 6(12):e28618. PubMed ID: 22205957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Down's syndrome and water fluoride level: a systematic review of the evidence.
    Whiting P; MacDonagh M; Kleijnen J
    BMC Public Health; 2001; 1():6. PubMed ID: 11495635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving gross motor function and postural control with hippotherapy in children with Down syndrome: case reports.
    Champagne D; Dugas C
    Physiother Theory Pract; 2010 Nov; 26(8):564-71. PubMed ID: 20673078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the quality of sitting and gait patterns in children with Down's syndrome.
    Lydic JS; Steele C
    Phys Ther; 1979 Dec; 59(12):1489-94. PubMed ID: 92793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understandings of Down's syndrome: a Q methodological investigation.
    Bryant LD; Green JM; Hewison J
    Soc Sci Med; 2006 Sep; 63(5):1188-200. PubMed ID: 16644080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdisciplinary therapy model for the infant with Down's syndrome.
    Harris SR
    Phys Ther; 1980 Apr; 60(4):420-3. PubMed ID: 6444730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurological complications in Down's Syndrome].
    Lev N; Melamed E
    Harefuah; 2002 Sep; 141(9):820-3, 857. PubMed ID: 12362489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olfactory dysfunction in Down's Syndrome.
    Murphy C; Jinich S
    Neurobiol Aging; 1996; 17(4):631-7. PubMed ID: 8832638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atlanto-occipital hypermobility in subjects with Down's syndrome.
    Matsuda Y; Sano N; Watanabe S; Oki S; Shibata T
    Spine (Phila Pa 1976); 1995 Nov; 20(21):2283-6. PubMed ID: 8553114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The aging of Down's Syndrome subjects].
    Fromage B; Anglade P
    Encephale; 2002; 28(3 Pt 1):212-6. PubMed ID: 12091781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.